在COVID-19患者中,细菌共感染的临床特征和危险因素:一项回顾性研究
Yichuan Gan1, Guowen Zhang1, Hengbiao Sun1
1Department of Clinical Laboratory, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, 510630, China.
在2019年冠状病毒病 (COVID-19) 患者中,细菌共同感染很常见,特别是在患有潜在疾病的老年人中. 严重的COVID-19病例面临来自多药耐药病原体的更高风险,强调需要及时预防.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 关键护理医学 关键护理医学
背景情况:
- 细菌共同感染复杂化了2019年新冠病毒病 (COVID-19) 管理.
- 了解这些共感染的流行病学和临床影响对于患者的治疗结果至关重要.
研究的目的:
- 分析COVID-19患者的细菌组成,药物敏感性和临床特征.
- 识别COVID-19中与细菌共感染相关的风险因素和常见病原体.
主要方法:
- 对184名COVID-19患者进行了回顾性研究.
- 收集和分析临床数据,包括人口统计,并发症和炎症标志物.
- 从各种临床样本中进行病原体隔离,鉴定和抗微生物敏感性测试.
主要成果:
- 患有潜在疾病的老年患者更容易受到细菌共同感染.
- 侵袭性手术和激素治疗被确定为显著的危险因素.
- 常见的病原体包括金黄色葡萄球菌,大肠杆菌,肺炎菌,青杆菌, Pseudomonas aeruginosa,在严重的肺炎中,耐药菌株的发病率越来越高.
结论:
- 呼吸道感染是COVID-19中细菌共同感染的最常见场所.
- 严重的COVID-19病例易患多药耐药性病原体,与较高的死亡率相关.
- 有效的联合感染控制和预防策略对于改善COVID-19患者预后至关重要.
更多相关视频
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
相关概念视频
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
